The clinical presentation of Guillain–Barré syndrome (GBS) is heterogeneous and, despite effective treatments, some patients die or sustain severe disabilities. An improved clinical prognostic score for GBS facilitates early identification of patients expected to have poor outcomes. These individuals might benefit from modified treatment or participation in therapeutic trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
van Koningsveld, R. et al. A clinical prognostic scoring system for Guillain–Barré syndrome. Lancet Neurol. 6, 589–594 (2007).
Walgaard, C. et al. Early recognition of poor prognosis in Guillain–Barré syndrome. Neurology 76, 968–975 (2011).
Hughes, R. A. et al. Immunotherapy for Guillain–Barré syndrome: a systematic review. Brain 130, 2245–2257 (2007).
Kuwabara, S. et al. Two patterns of clinical recovery in Guillain–Barré syndrome with IgG anti-GM1 antibody. Neurology 51, 1656–1660 (1998).
Jacobs, B. C. et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Ann. Neurol. 40, 181–187 (1996).
Jacobs, B. C. et al. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain–Barré syndrome. J. Neuroimmunol. 194, 181–190 (2008).
Kuitwaard, K. et al. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain–Barré syndrome. Ann. Neurol. 66, 597–603 (2009).
Visser, L. H. et al. Cytomegalovirus infection and Guillain–Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 47, 668–673 (1996).
Hadden, R. D. et al. Preceding infections, immune factors, and outcome in Guillain–Barré syndrome. Neurology 56, 758–765 (2001).
Kuwabara, S. Axonal Guillain–Barré syndrome is underestimated in Europe? J. Neurol. Neurosurg. Psychiatry 81, 1063 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Shahrizaila, N., Yuki, N. Clinical prognostic scales in Guillain–Barré syndrome. Nat Rev Neurol 7, 362–363 (2011). https://doi.org/10.1038/nrneurol.2011.93
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.93